| Mrs Pamela Jayne Young, BA, MS | |
|
605 S 6th St, Albion, NE 68620-1543 | |
| (402) 395-2134 | |
| Not Available |
| Full Name | Mrs Pamela Jayne Young |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 605 S 6th St, Albion, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629543574 | NPI | - | NPPES |
| 422 | Other | NE | NEBRASKA SPEECH-LANGUAGE PATHOLOGY LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 422 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela Jayne Young, BA, MS 267 W Fuller St, Albion, NE 68620-1816 Ph: (402) 395-6647 | Mrs Pamela Jayne Young, BA, MS 605 S 6th St, Albion, NE 68620-1543 Ph: (402) 395-2134 |
News Archive
A new report to be released at Columbia University's Earth Institute on April 26, 2004, suggests that heart disease and stroke are far more urgent threats to global health than commonly appreciated. They are causing hundreds of thousands of deaths each year in young people of productive age.
According to a new study the electromagnetic fields from cell phones excite the brain cortex adjacent to it and that possibly has implications for individuals with epilepsy, or other neurological conditions.
JAFRA Cosmetics International, Inc., a leader in direct-sales, today announced it has donated a portion of product sales, totaling more than $100,000, to help SOS Children's Villages construct a new village in Vietnam. The donation is part of a larger gift to the SOS Children's Villages that was made by JAFRA parent company, the Vorwerk Group, a family-owned business based in Germany.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
› Verified 8 days ago
Mrs. Katherine Lynn Bosak, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 723 W Fairview St, Albion, NE 68620 Phone: 402-395-3113 Fax: 402-395-3169 | |
Taylor Jaymes, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 723 W Fairview St, Albion, NE 68620 Phone: 402-395-3187 | |
Barbara Ann Olson, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1222 S 7th St, Albion, NE 68620 Phone: 402-395-6090 |